Clinical Trial Update: An Efficacy and Safety Study of Elagolix (NBI-56418) in Women With Endometriosis [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the efficacy and safety of elagolix (NBI-56418) in women with endometriosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Elagolix (elagolix)

Snippet

Sponsor: AbbVie | Conditions: Endometriosis, Pain | Phase 2 | Status: COMPLETED | Results posted: 2018-09-07